Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

R2P Metacross RX

K-Number: K163479 · 2017-01-11

ApplicantKANEKA Corporation
Decision Date2017-01-11
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

R2P Metacross RX is the device name listed in this FDA 510(k) record. The listed applicant is KANEKA Corporation. It received FDA 510(k) clearance on 2017-01-11 under 510(k) number K163479. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the R2P Metacross RX?

R2P Metacross RX is a medical device that received FDA 510(k) clearance on 2017-01-11. The listed applicant is KANEKA Corporation. The 510(k) number is K163479.

When did R2P Metacross RX receive FDA 510(k) clearance?

R2P Metacross RX received FDA 510(k) clearance on 2017-01-11, under 510(k) number K163479.

Who is the listed applicant for R2P Metacross RX?

The FDA 510(k) record lists KANEKA Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for R2P Metacross RX?

The FDA product code for R2P Metacross RX is LIT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07687472Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous MalformationNOT_YET_RECRUITING

Other records listing KANEKA Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K172264OTW Takeru PTCA Balloon Dilatation CatheterK170941RX NC Takeru PTCA Balloon Dilatation CatheterK163372RX Takeru Balloon Dilatation CatheterK160013Crosperio OTWK160004Crosstella OTWK152887Crosperio RX PTA Balloon Dilatation Catheter

View all 8 devices →

Related Devices (Code: LIT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260304WAVE PTA Balloon CatheterWAVE Medical AGK252512Armada™ 14 NC PTA CatheterABBOTT MEDICALK251915Amethyst HP PTA OTW 0.035 CatheterNatec Medical , Ltd.K250706Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation Catheters; Passeo-14 Peripheral Dilatation Catheter; Oscar Peripheral Multifunctional Catheter System; Pantera Pro Percutaneous Transluminal Coronary Angioplasty Catheter; Pantera LEO Percutaneous Transluminal Coronary Angioplasty (PTCA) CatheterBiotronik, Inc.K243704Parafleet SC 014 PTA Balloon Dilatation Catheter; Parafleet SC 018 PTA Balloon Dilatation Catheter; Parafleet SC 035 PTA Balloon Dilatation CatheterBrosmed Medical Co., Ltd.K241040Amethyst HP PTA OTW 0.035 CatheterNatec Medical , Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑